Peptide display in functional genomics.
The completion of the human genome project has opened novel scientific avenues in functional genomics, structural genomics and proteomics. These areas have a common goal: the identification of all the proteins acting and cross-talking in a single cell at a defined moment of its lifecycle. The expansion of these areas in bioscience has been facilitated by the rapid development of high throughput screening (HTS) methods which has, in turn, attracted the business community to make investments in this novel business segment of biotechnology. By using these HTS methods, the hope is that novel targets will be validated much more rapidly speeding up the development of novel drugs. Numerous techniques and tools have emerged over the past decade for the identification of small target-specific molecular ligands that exploit a common feature: the exploration of molecular diversity using combinatorial methods. While chemists developed new methods for rapidly and efficiently synthesising and screening large collections of small molecules, biologists used recombinant DNA techniques for selecting displayed repertoires. To this end, the discovery of new low molecular weight peptides is becoming increasingly important, not only as molecular tools for the understanding of protein-protein interactions but also for the generation of lead compounds.
SELEXIS SA, CBUE-LBTM, EPFL, Via della Ricerca Scientifica, Lausanne, 1015, Switzerland. igor.fisch@iba.unil.ch
I
I
Fisch
D003001:Cloning, Molecular / Q000379:methods*; D020650:Combinatorial Chemistry Techniques; D016678:Genome; D006801:Humans; D019151:Peptide Library
D019151:Peptide Library